Aveanna Healthcare Hldgs Analyst Ratings
Aveanna Healthcare Hldgs Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | -45.05% | Credit Suisse | → $1 | Reiterates | Underperform → Underperform |
| 07/13/2023 | -6.59% | Truist Securities | $1.4 → $1.7 | Maintains | Hold |
| 05/15/2023 | 9.89% | RBC Capital | → $2 | Reiterates | Sector Perform → Sector Perform |
| 05/12/2023 | -45.05% | Credit Suisse | → $1 | Reiterates | Underperform → Underperform |
| 05/12/2023 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 03/20/2023 | 9.89% | RBC Capital | $3 → $2 | Maintains | Sector Perform |
| 03/20/2023 | 64.84% | Raymond James | $4 → $3 | Maintains | Strong Buy |
| 03/17/2023 | -23.08% | Truist Securities | $1 → $1.4 | Maintains | Hold |
| 01/27/2023 | -45.05% | Credit Suisse | $2 → $1 | Downgrades | Neutral → Underperform |
| 11/21/2022 | 64.84% | RBC Capital | $7 → $3 | Downgrades | Outperform → Sector Perform |
| 11/17/2022 | 9.89% | Credit Suisse | $5.5 → $2 | Downgrades | Outperform → Neutral |
| 11/16/2022 | 119.78% | Raymond James | $6 → $4 | Maintains | Strong Buy |
| 11/11/2022 | -17.58% | Stephens & Co. | $2.25 → $1.5 | Maintains | Equal-Weight |
| 08/19/2022 | 174.73% | Barclays | $7 → $5 | Maintains | Overweight |
| 08/15/2022 | 229.67% | Raymond James | $8 → $6 | Maintains | Strong Buy |
| 07/22/2022 | 37.36% | Jefferies | $9 → $2.5 | Downgrades | Buy → Hold |
| 07/05/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 06/21/2022 | 92.31% | Stephens & Co. | $5.5 → $3.5 | Downgrades | Overweight → Equal-Weight |
| 03/31/2022 | 339.56% | Raymond James | $12 → $8 | Maintains | Strong Buy |
| 03/31/2022 | 394.51% | RBC Capital | $16 → $9 | Maintains | Outperform |
| 03/30/2022 | 174.73% | Truist Securities | $10 → $5 | Maintains | Buy |
| 03/30/2022 | 229.67% | Deutsche Bank | $12.5 → $6 | Maintains | Buy |
| 03/30/2022 | 284.62% | Stephens & Co. | $11.5 → $7 | Maintains | Overweight |
| 03/30/2022 | 284.62% | Barclays | $16 → $7 | Maintains | Overweight |
| 03/30/2022 | 421.98% | Credit Suisse | $12 → $9.5 | Maintains | Outperform |
| 03/29/2022 | 202.2% | B of A Securities | $10 → $5.5 | Downgrades | Buy → Neutral |
| 11/23/2021 | 559.34% | Raymond James | $15 → $12 | Maintains | Strong Buy |
| 05/24/2021 | 669.23% | JP Morgan | → $14 | Initiates Coverage On | → Neutral |
| 05/24/2021 | 724.18% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 05/24/2021 | 724.18% | Raymond James | → $15 | Initiates Coverage On | → Strong Buy |
| 05/24/2021 | 641.76% | Deutsche Bank | → $13.5 | Initiates Coverage On | → Buy |
| 05/24/2021 | 779.12% | Credit Suisse | → $16 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 834.07% | BMO Capital | → $17 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 779.12% | RBC Capital | → $16 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 998.9% | Barclays | → $20 | Initiates Coverage On | → Overweight |
| 05/24/2021 | 724.18% | Truist Securities | → $15 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月11日 | -45.05% | 瑞士信貸 | →$1 | 重申 | 表現不佳→表現不佳 |
| 07/13/2023 | -6.59% | Truist證券 | $1.4→$1.7 | 維護 | 保持 |
| 2023年05月15日 | 9.89% | 加拿大皇家銀行資本 | →$2 | 重申 | 扇區表現→扇區表現 |
| 2023年05月12日 | -45.05% | 瑞士信貸 | →$1 | 重申 | 表現不佳→表現不佳 |
| 2023年05月12日 | - | 雷蒙德·詹姆斯 | 評級下調 | 強勁的購買→市場表現 | |
| 03/20/2023 | 9.89% | 加拿大皇家銀行資本 | $3→$2 | 維護 | 行業表現 |
| 03/20/2023 | 64.84% | 雷蒙德·詹姆斯 | $4→$3 | 維護 | 強勢購買 |
| 03/17/2023 | -23.08% | Truist證券 | $1→$1.4 | 維護 | 保持 |
| 2023年1月27日 | -45.05% | 瑞士信貸 | $2→$1 | 評級下調 | 中性→表現不佳 |
| 2022年11月21日 | 64.84% | 加拿大皇家銀行資本 | $7→$3 | 評級下調 | 跑贏→板塊表現 |
| 2022年11月17日 | 9.89% | 瑞士信貸 | $5.5→$2 | 評級下調 | 跑贏→中性 |
| 2022年11月16日 | 119.78% | 雷蒙德·詹姆斯 | $6→$4 | 維護 | 強勢購買 |
| 2022年11月11日 | -17.58% | 斯蒂芬斯公司 | $2.25→$1.5 | 維護 | 等重 |
| 2022年08月19日 | 174.73% | 巴克萊 | $7→$5 | 維護 | 超重 |
| 2022年08月15日 | 229.67% | 雷蒙德·詹姆斯 | $8→$6 | 維護 | 強勢購買 |
| 07/22/2022 | 37.36% | 傑富瑞 | $9→$2.5 | 評級下調 | 購買→Hold |
| 07/05/2022 | - | Truist證券 | 評級下調 | 購買→Hold | |
| 2022年06月21日 | 92.31% | 斯蒂芬斯公司 | $5.5→$3.5 | 評級下調 | 超重→等重 |
| 03/31/2022 | 339.56% | 雷蒙德·詹姆斯 | $12→$8 | 維護 | 強勢購買 |
| 03/31/2022 | 394.51% | 加拿大皇家銀行資本 | $16→$9 | 維護 | 跑贏大盤 |
| 03/30/2022 | 174.73% | Truist證券 | $10→$5 | 維護 | 買 |
| 03/30/2022 | 229.67% | 德意志銀行 | $12.5→$6 | 維護 | 買 |
| 03/30/2022 | 284.62% | 斯蒂芬斯公司 | $11.5→$7 | 維護 | 超重 |
| 03/30/2022 | 284.62% | 巴克萊 | $16→$7 | 維護 | 超重 |
| 03/30/2022 | 421.98% | 瑞士信貸 | $12→$9.5 | 維護 | 跑贏大盤 |
| 03/29/2022 | 202.2% | B of A證券 | $10→$5.5 | 評級下調 | 購買→中性 |
| 2021年11月23日 | 559.34% | 雷蒙德·詹姆斯 | $15→$12 | 維護 | 強勢購買 |
| 2021/05/24 | 669.23% | 摩根大通 | →$14 | 開始承保 | →中性 |
| 2021/05/24 | 724.18% | 傑富瑞 | →$15 | 開始承保 | →購買 |
| 2021/05/24 | 724.18% | 雷蒙德·詹姆斯 | →$15 | 開始承保 | →強勢購買 |
| 2021/05/24 | 641.76% | 德意志銀行 | →$13.5 | 開始承保 | →購買 |
| 2021/05/24 | 779.12% | 瑞士信貸 | →$16 | 開始承保 | →跑贏大盤 |
| 2021/05/24 | 834.07% | 蒙特利爾銀行資本 | →$17 | 開始承保 | →跑贏大盤 |
| 2021/05/24 | 779.12% | 加拿大皇家銀行資本 | →$16 | 開始承保 | →跑贏大盤 |
| 2021/05/24 | 998.9% | 巴克萊 | →$20 | 開始承保 | →超重 |
| 2021/05/24 | 724.18% | Truist證券 | →$15 | 開始承保 | →購買 |
What is the target price for Aveanna Healthcare Hldgs (AVAH)?
Aveanna Healthcare Hldgs(Avah)的目標價格是多少？
The latest price target for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was reported by Credit Suisse on August 11, 2023. The analyst firm set a price target for $1.00 expecting AVAH to fall to within 12 months (a possible -45.05% downside). 15 analyst firms have reported ratings in the last year.
瑞士信貸於2023年8月11日報告了Aveanna Healthcare Hldgs(納斯達克：AVA)的最新目標價。這家分析公司將目標價定為1.00美元，預計Avah將在12個月內下跌(可能下跌45.05%)。過去一年，有15家分析公司公佈了評級。
What is the most recent analyst rating for Aveanna Healthcare Hldgs (AVAH)?
Aveanna Healthcare Hldgs(Avah)的最新分析師評級是多少？
The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was provided by Credit Suisse, and Aveanna Healthcare Hldgs reiterated their underperform rating.
瑞士信貸對Aveanna Healthcare Hldgs(納斯達克代碼：AVA)的最新分析師評級，Aveanna Healthcare Hldgs重申了其表現不佳的評級。
When is the next analyst rating going to be posted or updated for Aveanna Healthcare Hldgs (AVAH)?
Aveanna Healthcare Hldgs(Avah)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Aveanna Healthcare Hldgs的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Aveanna Healthcare Hldgs的上一次評級是在2023年8月11日提交的，所以你應該預計下一次評級將在2024年8月11日左右提供。
Is the Analyst Rating Aveanna Healthcare Hldgs (AVAH) correct?
分析師對Aveanna Healthcare Hldgs(Avah)的評級正確嗎？
While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a reiterated with a price target of $0.00 to $1.00. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $1.82, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Aveanna Healthcare Hldgs(Avah)評級重申，目標價在0.00美元至1.00美元之間。Aveanna Healthcare Hldgs(Avah)目前的股價為1.82美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。